குவாண்டா டயாலிசிஸ் தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குவாண்டா டயாலிசிஸ் தொழில்நுட்பங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குவாண்டா டயாலிசிஸ் தொழில்நுட்பங்கள் Today - Breaking & Trending Today

Investegate |Quanta Dialysis Technologies Announcements | Quanta Dialysis Technologies: QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer


QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer 
QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer 
Alcester, Warwickshire, UK, 12 February 2021: QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a British medical technology pioneer developing innovative dialysis products and services for the global market, today announces the appointment of
Dr Selwayan Saini as Chief Operating Officer with immediate effect.
Dr Saini brings with him over 15 years of experience working in senior operational roles in large global companies and in rapidly growing start-ups. Most recently he was Senior Director of Operations at Oxford Nanopore Technologies and prior to that he held various senior positions including CEO at Medtech Inside Biometrics and Vice President and Worldwide Director at Johnson & Johnson Medical Devices & Diagnostics. While at JNJ, he made significant contributions to chronic health management in the areas of diab ....

United Kingdom , Johne Milad , Selwayan Saini , Cranfield University , Dialysis Technologies Ltd , Apple Inc , Consilium Strategic Communications , Chief Operating Officer , Technologies Ltd , Senior Director , Oxford Nanopore Technologies , Medtech Inside Biometrics , Vice President , Worldwide Director , Johnson Medical Devices , Matthew Neal , Investegate Announcements , Investegate Company Announcements , Quanta Dialysis Technologies , Globe Newswire , Globenewswire And , ஒன்றுபட்டது கிஂக்டம் , ஜான் மீளத் , க்ர்யாந்‌ஃபீல்ட் பல்கலைக்கழகம் , டயாலிசிஸ் தொழில்நுட்பங்கள் லிமிடெட் , ஆப்பிள் இன்க் ,

Collaborate to Innovate 2020 awards shortlist announced


1st February 2021
11:23 am
We’re delighted to reveal the shortlist for The Engineer’s 2020 Collaborate To Innovate (C2I) Awards.
Now in its fifth year, The Engineer’s Collaborate To Innovate awards (C2I) was established to uncover and celebrate great examples of technology-led engineering collaboration across a range of different disciplines and sectors. It’s fair to say that it’s more than delivered on this vision, and has regularly uncovered a fresh pipeline of innovations, showcasing the UK’s strength and breadth in cross-disciplinary collaboration, and providing plenty of reasons to optimistic about the future of UK engineering. ....

City Of , United Kingdom , Sam Francis , Malvern Panalytical , Ansys Granta , Alan Newby , Neil Mcdougall , Toby Weymouth , Macneillie Babcock , Tractebel Engie , Kinneir Dufort , Steve Penver , Andy Wright , Rosa Wilkinson , University College London , Deputy Research , United Kingdom Ltd , James Fisher Nuclear , Strategic Technology , Bradford Metropolitan Council , University Of Edinburgh , Msc Group , Thermo Electric Devices Ltd , Manufacturing Technology , Gambia At London School Of Hygiene , United Kingdom Volcanology Field Robotics Team ,

Investegate |Quanta Dialysis Technologies Announcements | Quanta Dialysis Technologies: Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch


Quanta Dialysis Technologies
Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch
Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch
Quanta Receives FDA 510(k) Clearance for
the SC+ Hemodialysis System
Setting the Stage for US Market Launch
Alcester, Warwickshire, UK, 8 January 2021: Quanta Dialysis Technologies Ltd (“Quanta” or “the Company”), a British medical technology pioneer developing innovative dialysis products and services for the global market, today announces it has received 510(k) clearance from the US Food and Drug Administration (“FDA”) to market its small and simple, high performance hemodialysis system SC+. This critical milestone enables Quanta to bring to the American market its portable device that can provide a dialysis dose equivalent to today s standard of care, but in a compact, easy-to-use format suit ....

United Kingdom , United States , Amber Fennell , Johne Milad , Matthew Neal , John Lipman , Andrew Lazar , Lindsey Neville , Brigitte Schiller , Quanta Dialysis Technologies Ltd , Nephrology At Ahuja Medical Center , Drug Administration , Consilium Strategic Communications , National Health Service , Quanta Receives , Hemodialysis System Setting , Hemodialysis System , North America , Chronic Sales , Clinical Support , Chief Medical Officer , Satellite Healthcare , San Jose , Medical Advisory Board , Ahuja Medical Center , Kidney Medicine ,